The general aim of this project is to elucidate, at the molecular level, how heparin accelerates the inhibition of thrombin and factor Xa by antithrombin III. Rapid reaction kinetics, using stopped-flow and rapid quenching techniques, will be used extensively. We will attempt to quantitatively evaluate whether rate enhancement is due to approximation of the proteins on the heparin, a conformational change of antithrombin making it more reactive, or both. Intermediates in the protease neutralization reaction will be determined, as well as the rate limiting step in the catalytic turnover of heparin under various conditions. Kinetic properties of heparin action on factor Xa inactivation will be compared with those for thrombin neutralization, and the differential effects of heparin size evaluated. This project should result in increased understanding of how heparin increases the affinity between antithrombin and coagulation proteases, resulting in rate acceleration of inactivation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL030237-03
Application #
3341300
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1983-07-01
Project End
1986-12-31
Budget Start
1985-07-01
Budget End
1986-12-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Henry Ford Health System
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202